# [IRF4]

## Mutation tier

|Entity|Tier|
|------|----|
|DLBCL |1   |
|FL    |1   |

## Mutation incidence

|Entity|study         |frequency (%)|
|------|--------------|-------------|
|DLBCL |GAMBL genomes |3.20         |
|DLBCL |Schmitz cohort|7.00         |
|DLBCL |Reddy cohort  |4.40         |
|DLBCL |Chapuy cohort |2.10         |
|FL    |GAMBL genomes |1.15         |

## Mutation pattern

|Entity|aSHM|Significant selection|dN/dS (missense)|dN/dS (nonsense)|
|------|----|---------------------|----------------|----------------|
|BL    |Yes |No                   | 0.000          |0               |
|DLBCL |Yes |Yes                  |25.817          |0               |
|FL    |Yes |No                   | 0.000          |0               |

## aSHM regions

|chr_name|hg19_start|hg19_end|region|regulatory_comment|
|--------|----------|--------|------|------------------|
|chr6    |390572    |394093  |TSS   |active_promoter   |

> [!NOTE]
> First described in DLBCL in 2011 by [Morin RD](https://pubmed.ncbi.nlm.nih.gov/21796119)